Literature DB >> 24957322

Minimal supportive treatment in natalizumab-related PML in a MS patient.

Patrice H Lalive1, Claire Bridel2, Ruxandra Iancu Ferfoglia2, Laurent Kaiser3, Renaud Du Pasquier4, Frederik Barkhof5, Sven Haller6.   

Abstract

Entities:  

Keywords:  MRI; MULTIPLE SCLEROSIS

Mesh：

Substances：

Year:  2014        PMID： 24957322     DOI： 10.1136/jnnp-2014-308154

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Natalizumab-associated progressive multifocal leukoencephalopathy: successful treatment without plasma exchange and its associated risks.

Authors:  Eimer Maloney; Anna Molloy; Mariam Al Hussona; Luke O'Donnell; Ronan Killeen; Christopher McGuigan
Journal:  J Neurol       Date:  2016-12-30       Impact factor: 4.849

2.  Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review.

Authors:  Elizabeth C Neil; Lisa M DeAngelis
Journal:  Blood Adv       Date:  2017-10-18

3.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.